Essentials of Atrial Fibrillation

This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and i...

Full description

Bibliographic Details
Main Authors: Yap, Yee Guan (Author), Camm, A John (Author)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Language:English
Published: Tarporley : Springer Healthcare Ltd. : Imprint: Springer Healthcare, 2014.
Subjects:
Online Access:Full Text via HEAL-Link
LEADER 02521nam a22005415i 4500
001 978-1-907673-98-6
003 DE-He213
005 20151204190412.0
007 cr nn 008mamaa
008 140925s2014 xxk| s |||| 0|eng d
020 |a 9781907673986  |9 978-1-907673-98-6 
024 7 |a 10.1007/978-1-907673-98-6  |2 doi 
040 |d GrThAP 
050 4 |a RC1-1245 
072 7 |a MJ  |2 bicssc 
072 7 |a MED045000  |2 bisacsh 
082 0 4 |a 616  |2 23 
100 1 |a Yap, Yee Guan.  |e author. 
245 1 0 |a Essentials of Atrial Fibrillation  |h [electronic resource] /  |c by Yee Guan Yap, A John Camm. 
264 1 |a Tarporley :  |b Springer Healthcare Ltd. :  |b Imprint: Springer Healthcare,  |c 2014. 
300 |a VIII, 47 p. 11 illus., 4 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Epidemiology of atrial fibrillation -- Pathogenesis of atrial fibrillation -- Classification, diagnosis, and assessment of atrial fibrillation -- Rate and rhythm control strategies for atrial fibrillation -- Anticoagulant treatment strategies for atrial fibrillation. 
520 |a This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events. 
650 0 |a Medicine. 
650 0 |a Public health. 
650 0 |a Internal medicine. 
650 0 |a Cardiology. 
650 0 |a Hematology. 
650 0 |a Primary care (Medicine). 
650 0 |a Pharmacotherapy. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Internal Medicine. 
650 2 4 |a Public Health. 
650 2 4 |a Cardiology. 
650 2 4 |a Hematology. 
650 2 4 |a Primary Care Medicine. 
650 2 4 |a Pharmacotherapy. 
700 1 |a Camm, A John.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781858734385 
856 4 0 |u http://dx.doi.org/10.1007/978-1-907673-98-6  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)